Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Dicerna, City of Hope National Medical Center deal

Dicerna received exclusive rights to the center's IP covering therapeutic

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE